Search results for "Vasculoprotection"

showing 2 items of 2 documents

Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need gor Early Biomarkers snd Cardio- snd Vasculo-Protection…

2018

The use of chemotherapy has largely improved the prognosis of cancer patients in the past two decades. However, the advent of more effective anticancer therapies has led to a higher incidence of cardiovascular toxicity that shows an increased incidence and represents a significant determinant of quality of life and mortality during ongoing treatment and in long-term survivors of cancer. In this setting, the primary objective for cardiologists and oncologists is the early identification of patients at high risk for developing cardiovascular toxicity and the identification of the cardiovascular cardiotoxicity in the earliest stages to personalize cancer therapy, arrange preventive interventio…

Cardiovascular toxicityCardiotoxicitymedicine.medical_specialtyChemotherapyVascular Toxicitybusiness.industryIncidence (epidemiology)medicine.medical_treatmentBiomarkers Omics Cardioprotection Vasculoprotection Cardiotoxicity Vascular Toxicity Anticancer drugsVasculoprotectionCancerOmicsCardioprotectionmedicine.diseaseOmicsAnticancer drugsCardiotoxicityQuality of lifemedicinePersonalized therapyIntensive care medicinebusinessBiomarkers
researchProduct

Aging Successfully: The Role of Genetics and Environment in the Era of the Aging-Boom. Potential Therapeutic Implications

2019

Aging is one of the main health-related challenges in the world. The average life expectancy of the global population at birth is increasing up to 72 years, in 2016 and it increases about two years every decade. The healthcare costs in many countries are very high because of the increased number of unhealthy populations, and the consequent increase of severe age-related disabilities [1]. Therefore, the goal of the future should be the achievement of the so-called “health-span” (healthy-life-span), more than the treatment of age-related disease to prevent the collapse of the health system. In order to achieve this objective, it is necessary to identify new targets and biomarkers and to addre…

GerontologyAgingEye DiseasesLongevityMEDLINEAging Anti-aging strategies DNA methylation Immunesenescence TLR agonist Immunesenescence Melatonin MiRNA Neuroinflammation Vasculoprotection01 natural sciencesBoomEpigenesis Genetic03 medical and health sciencesDrug DiscoveryHumansMedicineMelatonin030304 developmental biologyEpigenesisSettore MED/04 - Patologia GeneralePharmacology0303 health sciencesbusiness.industryToll-Like ReceptorsVaccination0104 chemical sciencesMicroRNAs010404 medicinal & biomolecular chemistryMethotrexateImmune SystembusinessIntroductory Journal ArticleCurrent Pharmaceutical Design
researchProduct